The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 3-7C Hodgkin Lymphoma

Sun. Oct 13, 2019 2:30 PM - 3:30 PM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Kazuhito Yamamoto (Aichi Cancer Center, Department of Hematology and Cell Therapy)

Kazuyuki Shimada1, Pier L. Zinzani2, Akihiro Tomita1, Kenichi Ishizawa3, Shinichiro Okamoto4, Itaru Matsumura5, Yoshinobu Maeda6, Koji Kato7, Akira Wakana8, Eunhee Kim9, Mohammed Farooqui9, Akash Nahar9, Takashi Shimamoto8, Yasuhiro Koh8, Craig H. Moskowitz10, Takanori Teshima11 (1.Nagoya University, Nagoya, Japan, 2.Institute of Hematology, University of Bologna, Bologna, Italian Republic, 3.Yamagata University, Yamagata, Japan, 4.Keio University, Tokyo, Japan, 5.Kindai University, Osaka, Japan, 6.Okayama University, Okayama, Japan, 7.Kyushu University, Fukuoka, Japan, 8.MSD K.K., Tokyo, Japan, 9.Merck & Co., Inc., Kenilworth, NJ, United States of America, 10.University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, United States of America, 11.Hokkaido University Hospital, Hokkaido, Japan)

Yasuhito Terui1, Dai Maruyama2, Kazuhito Yamamoto3, Noriko Fukuhara4, Ilseung Choi5, Junya Kuroda6, Kiyoshi Ando7, Akira Hattori8, Kensei Tobinai2 (1.Cancer Inst. Hosp. JFCR, Tokyo, Japan, 2.Natl. Cancer Ctr. Hosp., Tokyo, Japan, 3.Aichi Cancer Ctr., Nagoya, Japan, 4.Tohoku Univ. Grad. Sch. Med., Sendai, Japan, 5.NHO Kyushu Cancer Ctr., Fukuoka, Japan, 6.Kyoto Pref. Univ. Med., Kyoto, Japan, 7.Tokai Univ., Isehara, Japan, 8.Ono Pharmaceutical Co., Ltd, Osaka, Japan)